Thierry Alcindor, MD MSc

Medical Oncologist
Dana-Farber Cancer Institute

Dr. Thierry Alcindor graduated from Universite d'Etat d'Haiti (MD) and University of Oxford (MSc.) He obtained postgraduate training at Yale and Tufts. He was previously Director of Medical Oncology at McGill University Health Centre and is currently a medical oncologist at the Dana-Farber Cancer Institute in Boston. He has been involved in ASCO and ESMO scientific/education committees and was co-chair then chair of the Sarcoma Committee of the Canadian Cancer Trials Group.

Poster(s):

• (P 092) THE SARCOMA-SPECIFIC QUALITY OF LIFE STUDY (SARC-QOL): IDENTIFYING KEY DOMAINS OF HEALTH-RELATED QUALITY OF LIFE IN ADULT PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMA

• (P 102) EFFICACY AND SAFETY OF VIMSELTINIB IN TENOSYNOVIAL GIANT CELL TUMOUR: PHASE 2 EXPANSION

• (P 165) REAL- WORLD EXPERIENCE OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH RECURRENT BONE TUMOURS (BT): A CANSARCC STUDY